Mark Cuban Cost Plus Drug Company, PBC Joins Forces with Seva-Rx to Expand Transparent, Affordable Prescription Access
June 30, 2025 – Dallas, TX & Crown Point, IN
The Mark Cuban Cost Plus Drug Company, PBC (“Cost Plus Drugs”) announced today a new joint venture with Seva-Rx, a forward-thinking Pharmacy Benefit Manager (PBM) committed to transparency and innovation in prescription drug access.
Through this collaboration, Seva-Rx members will now have access to the Cost Plus Drugs platform, which offers a wide range of prescription medications at cost, plus a flat 15% markup, a $5 pharmacy fee, and shipping. The joint venture reflects a shared mission between both companies: to make medications more accessible, affordable, and free from traditional middlemen markups.
“At Seva-Rx, we are redefining what it means to be a Pharmacy Benefit Manager. Transparency and affordability are the foundation of our model,” said Dr. Kirnjot Singh, President of Seva-Rx. “The joint venture with Mark Cuban and his team allows us to offer our clients direct access to some of the most fairly priced medications in the country, with no hidden rebates or spread pricing.”
Cost Plus Drugs, launched by entrepreneur Mark Cuban, continues to disrupt the prescription drug industry by working directly with manufacturers and pharmacies to provide low-cost medications directly to consumers. By aligning with PBMs like Seva-Rx, Cost Plus Drugs extends its reach to employer groups, health plans, and other institutional purchasers looking for cost savings without compromising quality.
“We are excited to join forces with a like-minded company such as Seva-Rx”, said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “At Cost Plus Drugs, we are committed to revolutionizing the pharmaceutical landscape through transparent drug pricing and working with Seva-Rx aligns seamlessly with our mission. Together, we are ensuring affordability, accessibility, and clarity in medication costs, empowering individuals to make informed choices about their health and well-being.”
The integration is now live, and Seva-Rx clients can begin leveraging Cost Plus Drugs for eligible prescriptions effective immediately.
For more information about the Mark Cuban Cost Plus Drug Company, visit http://www.costplusdrugs.com. To learn more about Seva-Rx’s pharmacy benefit model, visit http://www.seva-rx.com.
Media Contacts:
Seva-Rx
Director of Communications
Mark Cuban Cost Plus Drug Company
Media Relations
Email: press@costplusdrugs.com
Leave a reply